Cryder Capital Partners LLP grew its stake in shares of Marsh & McLennan Companies, Inc. (NYSE:MRSH - Free Report) by 32.5% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 477,744 shares of the financial services provider's stock after acquiring an additional 117,115 shares during the quarter. Marsh & McLennan Companies comprises about 5.2% of Cryder Capital Partners LLP's investment portfolio, making the stock its 10th biggest holding. Cryder Capital Partners LLP owned 0.10% of Marsh & McLennan Companies worth $88,631,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors have also recently made changes to their positions in the company. Numerai GP LLC lifted its stake in shares of Marsh & McLennan Companies by 966.2% in the 3rd quarter. Numerai GP LLC now owns 37,220 shares of the financial services provider's stock worth $7,501,000 after purchasing an additional 33,729 shares during the period. Rockland Trust Co. lifted its stake in shares of Marsh & McLennan Companies by 801.6% in the 3rd quarter. Rockland Trust Co. now owns 12,073 shares of the financial services provider's stock worth $2,433,000 after purchasing an additional 10,734 shares during the period. Barclays PLC lifted its stake in shares of Marsh & McLennan Companies by 41.7% in the 3rd quarter. Barclays PLC now owns 2,202,372 shares of the financial services provider's stock worth $443,844,000 after purchasing an additional 647,987 shares during the period. Navera Investment Management Ltd. lifted its stake in shares of Marsh & McLennan Companies by 7.0% in the 3rd quarter. Navera Investment Management Ltd. now owns 1,623,960 shares of the financial services provider's stock worth $327,303,000 after purchasing an additional 105,954 shares during the period. Finally, Bridges Investment Management Inc. lifted its stake in shares of Marsh & McLennan Companies by 4.4% in the 3rd quarter. Bridges Investment Management Inc. now owns 76,196 shares of the financial services provider's stock worth $15,356,000 after purchasing an additional 3,177 shares during the period. Hedge funds and other institutional investors own 87.99% of the company's stock.
Marsh & McLennan Companies Trading Up 0.0%
Shares of NYSE:MRSH opened at $167.30 on Wednesday. Marsh & McLennan Companies, Inc. has a 12-month low of $164.89 and a 12-month high of $235.78. The firm has a fifty day moving average of $173.34. The stock has a market cap of $80.60 billion, a P/E ratio of 20.91, a PEG ratio of 2.45 and a beta of 0.65. The company has a debt-to-equity ratio of 1.28, a current ratio of 1.11 and a quick ratio of 1.11.
Marsh & McLennan Companies (NYSE:MRSH - Get Free Report) last announced its quarterly earnings results on Thursday, April 16th. The financial services provider reported $3.29 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $3.21 by $0.08. The business had revenue of $7.30 billion for the quarter. Marsh & McLennan Companies had a return on equity of 31.87% and a net margin of 14.26%.The company's revenue was up 7.6% on a year-over-year basis. Research analysts predict that Marsh & McLennan Companies, Inc. will post 10.36 EPS for the current year.
Marsh & McLennan Companies Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Friday, May 15th. Investors of record on Thursday, April 9th will be paid a $0.90 dividend. The ex-dividend date is Thursday, April 9th. This represents a $3.60 dividend on an annualized basis and a yield of 2.2%. Marsh & McLennan Companies's dividend payout ratio (DPR) is 45.00%.
Analysts Set New Price Targets
MRSH has been the topic of several recent research reports. Citigroup increased their price objective on shares of Marsh & McLennan Companies from $201.00 to $205.00 and gave the stock a "neutral" rating in a research note on Tuesday, February 3rd. Raymond James Financial raised shares of Marsh & McLennan Companies from an "outperform" rating to a "strong-buy" rating and set a $225.00 target price for the company in a report on Tuesday, February 17th. Royal Bank Of Canada reissued a "sector perform" rating and issued a $200.00 target price on shares of Marsh & McLennan Companies in a report on Friday, January 30th. Wells Fargo & Company reduced their target price on shares of Marsh & McLennan Companies from $203.00 to $178.00 and set an "equal weight" rating for the company in a report on Thursday, April 9th. Finally, Cantor Fitzgerald increased their target price on shares of Marsh & McLennan Companies from $208.00 to $212.00 and gave the stock an "overweight" rating in a report on Monday, February 2nd. One research analyst has rated the stock with a Strong Buy rating, five have given a Buy rating, ten have assigned a Hold rating and one has given a Sell rating to the company's stock. According to MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average price target of $205.33.
Get Our Latest Report on MRSH
Insider Transactions at Marsh & McLennan Companies
In other Marsh & McLennan Companies news, CEO John Q. Doyle sold 16,655 shares of the firm's stock in a transaction that occurred on Wednesday, March 4th. The shares were sold at an average price of $183.30, for a total transaction of $3,052,861.50. Following the completion of the transaction, the chief executive officer directly owned 116,811 shares of the company's stock, valued at approximately $21,411,456.30. This trade represents a 12.48% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. 0.38% of the stock is owned by company insiders.
Marsh & McLennan Companies Profile
(
Free Report)
Marsh & McLennan Companies NYSE: MMC is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.
The firm operates through several well-known subsidiaries and business units that specialize in distinct services.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Marsh & McLennan Companies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Marsh & McLennan Companies wasn't on the list.
While Marsh & McLennan Companies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report